Dr. Richard Zelman | Understanding Left Ventricular Assist Devices (LVADs)
LVADs are mechanical pumps that are surgically implanted to assist the left ventricle, the heart’s main pumping chamber, in circulating blood throughout the body. Initially developed as a temporary solution for patients awaiting heart transplantation (bridge-to-transplant therapy), LVADs have evolved to become a viable long-term treatment option for those who are not candidates for transplantation (destination therapy).
Dr. Zelman explains that LVADs work by taking over the
pumping function of the left ventricle, helping to maintain adequate blood flow
and reduce symptoms associated with heart failure, such as fatigue, shortness
of breath, and fluid retention. By supporting the failing heart, LVADs can
significantly improve a patient's quality of life, increase survival rates, and
reduce hospitalizations.
Heart failure, a condition where the heart is unable to pump
sufficient blood to meet the body’s needs, affects millions of people worldwide
and remains a leading cause of morbidity and mortality. For patients with
advanced heart failure who are not eligible for heart transplantation or are on
long waiting lists, Left Ventricular Assist Devices (LVADs) have emerged as a
life-saving alternative. These mechanical devices help the heart pump blood
more effectively. Dr.
Richard Zelman, a renowned cardiologist and researcher, has been at the
forefront of advancements in LVAD technology, advocating for improved designs
and applications to enhance patient outcomes and quality of life.
Comments
Post a Comment